Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

February 17, 2026 09:19 ET | Source: The Juvenile Diabetes Cure Alliance

JDCA Releases First-of-Its-Kind Report of Companies Working on a Diabetes Cure

NEW YORK, Feb. 17, 2026 (GLOBE NEWSWIRE) -- The Juvenile Diabetes Cure Alliance (JDCA), a 501(c)(3) nonprofit focused on accelerating a cure for type 1 diabetes (T1D), announced the release of a...
February 09, 2026 07:28 ET | Source: Arch Biopartners

Arch Biopartners Scientists Publish New Data Linking the Cytokine IL-32 to Inflammation and Diabetic Kidney Disease

TORONTO, Feb. 09, 2026 (GLOBE NEWSWIRE) -- Arch Biopartners Inc. (“Arch” or the “Company”) (TSX Venture: ARCH and OTCQB: ACHFF) today announced that a scientific team led by Dr. Justin Chun at the...
February 09, 2026 06:05 ET | Source: MannKind

MannKind Announces First Patient Enrolled in INHALE-1ST Pediatric Study Evaluating Afrezza® for Youth with Newly-Diagnosed Type 1 Diabetes (T1D)

MannKind Announces First Patient Enrolled in INHALE-1ST Pediatric Study Evaluating Afrezza® for Youth with Newly-Diagnosed Type 1 Diabetes (T1D)
February 09, 2026 03:30 ET | Source: Breye Therapeutics

Strong clinical data for Breye Therapeutics’ lead oral asset danegaptide presented at Angiogenesis, Exudation and Degeneration 2026 symposium

Prof. Carl D. Regillo, MD, presented clinical data from the Phase 1b trial evaluating Breye Therapeutics’ lead candidate, danegaptide, in 24 patients with non-proliferative diabetic retinopathy (NPDR)...
February 03, 2026 18:35 ET | Source: YMCA of Northern Alberta

Free YMCA diabetes program to help people lower risk and stay healthy is expanding across Edmonton

Free diabetes prevention program expands to all YMCA health, fitness and aquatics centres in Edmonton.
February 03, 2026 11:36 ET | Source: Socrates Health Solutions Inc.

Socrates Health Solutions Announces Advances in Proprietary Non-Invasive Glucose Monitoring Technology; Shareholders Include NFL Players Association and OneTeam Partners

Socrates Health Solutions Announces Advances in Proprietary Non-Invasive Glucose Monitoring Technology; Shareholders Include NFL Players Association and On
January 28, 2026 02:00 ET | Source: GlucoModicum

Newly published research further validates GlucoModicum’s path to high-precision, non-invasive glucose monitor

The study explains the mechanism behind up to 100× sensitivity amplification in glucose sensorsThe article was published in Biosensors and Bioelectronics, the leading peer-reviewed journal in the...
January 26, 2026 06:05 ET | Source: MannKind

MannKind Announces FDA Approval of Updated Afrezza® Label Providing Starting Dose Guidance when Switching from Multiple Daily Injections (MDI) or Insulin Pump Mealtime Therapy

MannKind Announces FDA Approval of Updated Afrezza® Label Providing Starting Dose Guidance when Switching from Multiple Daily Injections (MDI) or Insulin
January 22, 2026 04:17 ET | Source: Research and Markets

Global Needle-Free Diabetes Care Market Set to Reach USD 19.88 Billion by 2032, Revolutionizing Chronic Disease Management

Dublin, Jan. 22, 2026 (GLOBE NEWSWIRE) -- The "Needle Free Diabetes Care Market - Global Forecast 2026-2032" has been added to ResearchAndMarkets.com's offering.The Needle Free Diabetes Care Market...
January 20, 2026 03:00 ET | Source: Nxera Pharma

Nxera Pharma Establishes Metabolic Advisory Council to Advance Next-Generation Therapies for Obesity and Metabolic Disorders

Council brings together leading global scientific and clinical experts in metabolic diseases to guide development of Nxera’s expanding proprietary pipeline Tokyo, Japan and Cambridge, UK, 20...